Boston Scientific (BSX) Net Cash Flow (2016 - 2025)
Historic Net Cash Flow for Boston Scientific (BSX) over the last 17 years, with Q4 2025 value amounting to $668.0 million.
- Boston Scientific's Net Cash Flow rose 13284.17% to $668.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.5 billion, marking a year-over-year increase of 44223.74%. This contributed to the annual value of $1.5 billion for FY2025, which is 44223.74% up from last year.
- Latest data reveals that Boston Scientific reported Net Cash Flow of $668.0 million as of Q4 2025, which was up 13284.17% from $737.0 million recorded in Q3 2025.
- Boston Scientific's 5-year Net Cash Flow high stood at $1.4 billion for Q1 2024, and its period low was -$2.0 billion during Q4 2024.
- Over the past 5 years, Boston Scientific's median Net Cash Flow value was $27.5 million (recorded in 2021), while the average stood at $7.0 million.
- Per our database at Business Quant, Boston Scientific's Net Cash Flow skyrocketed by 684444.44% in 2022 and then tumbled by 241111.11% in 2024.
- Quarter analysis of 5 years shows Boston Scientific's Net Cash Flow stood at $9.0 million in 2021, then skyrocketed by 6844.44% to $625.0 million in 2022, then plummeted by 112.96% to -$81.0 million in 2023, then plummeted by 2411.11% to -$2.0 billion in 2024, then soared by 132.84% to $668.0 million in 2025.
- Its Net Cash Flow stands at $668.0 million for Q4 2025, versus $737.0 million for Q3 2025 and -$180.0 million for Q2 2025.